Lisa M. Kopp

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

Cecele J. Denman, V. V. Senyukov, Srinivas S. Somanchi et al. · PLoS ONE · 2012 · 647 citations · Full text

Cell Therapy, Immunology, Nk Cells +16

Phase II trial of the glycoprotein non-metastatic B-targeted antibody–drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group

Lisa M. Kopp, Suman Malempati, Mark Krailo et al. · European Journal of Cancer · 2019 · 76 citations · Full text

Phase Ii Trial, Medicine, Immunology +8

Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions

Lisa M. Kopp, Anish Ray, Cecele J. Denman et al. · Molecular Immunology · 2013 · 68 citations

Biphasic Effect, Immunology, Cell Death +4

Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer

Eric J. Chow, Sanjeev Aggarwal, David R. Doody et al. · Journal of Clinical Oncology · 2023 · 68 citations · Full text

Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group

Eric J. Chow, Richard Aplenc, Lynda M. Vrooman et al. · Cancer · 2021 · 53 citations · Full text